Neihulizumab (ALTB-168) in Patients with Steroid-Refractory Acute Graft-Versus-Host-Disease (SR-aGVHD) or Treatment-Refractory Acute Graft-Versus-Host-Disease (TR-aGVHD)
Blood (2022) 140 (Supplement 1): 10495–10497.
Currently there are no citedby results. Try again later.
